Kiniksa Pharmaceuticals, Ltd. (KNSA) Investor Relations Documents

Kiniksa Pharmaceuticals, Ltd. (KNSA) investor relations documents from the company's IR site: 3 presentations, 18 press releases; latest deck 2026-07-28. Read in-app with summaries. First-party data.

Corporate Presentation – July 2026: Kiniksa Pharmaceuticals reports Q2 2026 financial strength with $526M in cash and projects 2026 ARCALYST revenue between $980M and $995M.

Investor relations documents — source: company IR site

Published	Type	Document
2026-07-28	Presentation	Corporate Presentation – July 2026
2026-07-28	Earnings deck	Kiniksa Pharmaceuticals Second Quarter 2026 Earnings Conference Call
2026-07-28	Press release	Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution
2026-07-23	Press release	Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026
2026-04-28	Earnings deck	First Quarter 2026 Earnings Presentation
	Press release	Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution
	Press release	Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026
2026-02-24	Press release	Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
2026-02-19	Press release	Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
	Press release	Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
	Press release	Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025
	Press release	Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution
	Press release	Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025
	Press release	Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution
	Press release	Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025
	Press release	Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution
	Press release	Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
2024-07-23	Press release	Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution
2024-07-16	Press release	Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024
2024-07-25	Document	0001558370-24-010181.pdf
2024-04-23	Press release	Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
2024-04-16	Press release	Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
2023-05-04	Document	0001558370-23-008113.pdf
2022-05-06	Document	0001558370-22-007381.pdf

KNSA overview · KNSA earnings · KNSA financials · KNSA KPIs · KNSA documents · KNSA ownership · KNSA peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.